Structural organization of binding determinants in the molecule of insulin-like growth factor-I (IGF-I) |
| |
Authors: | A P Kolychev |
| |
Institution: | (1) Department of Biotechnology, University of New South Wales, Kensington, NSW, 2052, Australia.;(2) Department of Biotechnology, University of New South Wales, Kensington, NSW, 2052, Australia;(3) CRC for Biopharmaceutical Research, University of New South Wales, Kensington, NSW, 2052, Australia |
| |
Abstract: | Insulin-like growth factor I (IGF-I) is a peptide related to insulin and IGF-II. These three related peptides produce similar
biological effects, but each of them has its irreplaceable physiological significance in the organism. Multisided functional
role of IGF-I in the organism is due to its unique binding properties. Specifically, but with different degree of affinity,
it is able to interact with three receptors (IGF-I-receptor, insulin receptor, and IGF-II-receptor) and six binding proteins
(IGFBP 1–6). To interact with each of the above objects, the IGF-I molecule contains individual structural determinants—binding
domains (BD) providing strict specificity of interaction with them. Responsible for the IGF-I biological effects and binding
with IGF-I-receptor is α-domain, for binding with insulin receptor—β-, EGF-II—γ-, while with all BP—δ-BD, respectively. Results
of experimental study of binding domains not always can be estimated unanimously. The proposed by the author system of criteria
for evaluation of changes in affinity of the IGF-I analogies allows unraveling the structural organization of each of the
domains and tracing dependence on it of the peptide affinity to the particular object. This work considers composition, organization,
and principle of formation of affinity of three binding IGF-I domains (α-, γ-, and δ-BD). The α-domain includes three tyrosines
from three different molecule sites (B-24, C-31, and A-60) disposed spatially in the direct vicinity on its one surface. The
β-domain also is considered as the domain participating in the high-affinity interaction; by composition and location in molecule
it principally differs from α-BD, with the structural organization that so far has not been deciphered. Analyzed in detail
is the key significance of the N-terminal site of the B-chain—the linear site of the domain—for binding of IGF-I with BP,
functional heterogeneity of its constituent residues, and the characteristic principle of formation of affinity to BP. Analysis
indicates a probability of the second δ-BD, quite possibly not the only one, and a high sensitivity of the domain to configuration
of the IGH-I molecule surface. Structural organization and peculiarities of formation of affinity in the γ-domain are studied
the best in three related peptides; it consists of two linearly exposed sites of A-chain. Composition of the site S-1 A (Phen8,
Arg9, Ser10) provides a possibility of binding the ligand with IGF-I-receptor, while the level of affinity to it depends on
the composition of S-2. The S-2 A composition (Arg14, Arg15) determines the low affinity of IGF-I to the IGF-II-receptor.
The clear functioning of IGF-I and elimination of mixture of functions at the level of the binding activity depend on the
spatial autonomy of BD of different nature, difference in structural organization of each of the domains, and a peculiarity
of principles of formation of affinity in each case. The spatial coordination of several BD sites is the condition for transmission
of the “structural signal“ by regulatory peptide. The performed analysis provides the direct notion of dependence of the binding
ability of the IGF-I molecule that has BD of different nature on their structural peculiarities and allows using the revealed
regularities at searching for BD in the newly discovered insulinlike peptides. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|